Alector reports third quarter 2020 financial results and provides corporate update

South san francisco, calif., nov. 10, 2020 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced corporate updates and financial results for the third quarter ended september 30, 2020.
ALEC Ratings Summary
ALEC Quant Ranking